Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - sodium valproate - gastro-resistant tablet - 200mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - sodium valproate - gastro-resistant tablet - 500mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - sodium valproate - gastro-resistant tablet - 500mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - sodium valproate - gastro-resistant tablet - 200mg

Velká Británie - angličtina - myHealthbox

wockhardt uk ltd - sodium valproate - enteric coated tablet - 200mg - antiepileptics - in the treatment of generalised, partial or other epilepsy.

Velká Británie - angličtina - myHealthbox

wockhardt uk ltd - sodium valproate - enteric coated tablet - 500mg - antiepileptics - in the treatment of generalised, partial or other epilepsy.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - sodium valproate 100 mg/ml - solution for injection - 100 mg/ml - active: sodium valproate 100 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic potassium phosphate water for injection - the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.